Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Gastrointestinal Stromal Neoplasms”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT04241276
What this trial is testing

A Randomised Trial of ATRA in a Novel Drug Combination for Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Queen Mary University of London 170
Large-scale testing (Phase 3)UnknownNCT02576080
What this trial is testing

Efficacy of Imatinib in Patients With Intermediate-risk Gastrointestinal Stromal Tumor With a High-risk Genomic Grade Index

Who this might be right for
Gastrointestinal Stromal Tumor
Assistance Publique Hopitaux De Marseille 80
Not applicableStudy completedNCT04599660
What this trial is testing

Study in Low Risk Gastrointestinal Stromal Tumor (GISTs)

Who this might be right for
GIST
Italian Sarcoma Group 700
Not applicableLooking for participantsNCT07405125
What this trial is testing

Safety of Robotic Surgery for GISTs at Special Anatomic Sites

Who this might be right for
Gastrointenstinal Stromal Tumor (GIST)
The First Affiliated Hospital with Nanjing Medical University 182
Testing effectiveness (Phase 2)Study completedNCT00464620
What this trial is testing

Trial of Dasatinib in Advanced Sarcomas

Who this might be right for
RhabdomyosarcomaMalignant Peripheral Nerve Sheath TumorsChondrosarcoma+7 more
Sarcoma Alliance for Research through Collaboration 366
Testing effectiveness (Phase 2)Study completedNCT00005862
What this trial is testing

SU5416 in Treating Patients With Advanced, Metastatic, or Recurrent Soft Tissue Sarcomas

Who this might be right for
Gastrointestinal Stromal TumorSarcoma
National Cancer Institute (NCI) 60
Not applicableUnknownNCT05440357
What this trial is testing

Second-line Pharmacotherapy Patterns and Outcomes of Advanced Gastrointestinal Stromal Tumor: A Real-world Study

Who this might be right for
Gastrointestinal Stromal Tumors
Xinhua Zhang, MD 100
Testing effectiveness (Phase 2)Study completedNCT00171912
What this trial is testing

Imatinib Mesylate in Patients With Various Types of Malignancies Involving Activated Tyrosine Kinase Enzymes

Who this might be right for
Hypereosinophilic SyndromeSystemic MastocytosisChronic Myelomonocytic Leukemia+1 more
Novartis Pharmaceuticals 38
Early research (Phase 1)Study completedNCT00135005
What this trial is testing

Study of AMN107 With Imatinib in Gastrointestinal Stromal Tumors (GIST)

Who this might be right for
Gastrointestinal Stromal Tumors
Novartis Pharmaceuticals 59
Not applicableStudy completedNCT03722056
What this trial is testing

Laparoscopic Management of Gastrointestinal Stromal Tumor of Stomach

Who this might be right for
Gastric GISTSubmucosal Tumor of Stomach
GEM Hospital & Research Center 42
Testing effectiveness (Phase 2)Study completedNCT02712112
What this trial is testing

Intermittent Dosing Schedule of Imatinib in Patients With Tyrosine Kinase Inhibitor Refractory GISTs

Who this might be right for
Gastrointestinal Stromal Tumors (GISTs)
Asan Medical Center 51
Testing effectiveness (Phase 2)UnknownNCT01389583
What this trial is testing

AUY922 for GIST(Gastrointestinal Stromal Tumor) Patients

Who this might be right for
Gastrointestinal Stromal Tumor
National Health Research Institutes, Taiwan 25
Testing effectiveness (Phase 2)Study completedNCT03556384
What this trial is testing

Temozolomide (TMZ) In Advanced Succinate Dehydrogenase (SDH)-Mutant/Deficient Gastrointestinal Stromal Tumor (GIST)

Who this might be right for
Gastrointestinal Stromal TumorsSdhGIST+1 more
Adam Burgoyne, MD, PhD 23
Large-scale testing (Phase 3)Ended earlyNCT00956072
What this trial is testing

Imatinib Mesylate With or Without Surgery in Treating Patients With Metastatic Gastrointestinal Stromal Tumor That is Responding to Imatinib Mesylate

Who this might be right for
Gastrointestinal Stromal Tumor
European Organisation for Research and Treatment of Cancer - EORTC 12
Large-scale testing (Phase 3)Study completedNCT01694277
What this trial is testing

Masitinib in Patients With Gastrointestinal Stromal Tumour After Progression With Imatinib

Who this might be right for
Gastrointestinal Stromal Tumors
AB Science 258
Testing effectiveness (Phase 2)Looking for participantsNCT07096609
What this trial is testing

Lenvatinib After Progression on Imatinib, Sunitinib, and Regorafenib for GIST Patients

Who this might be right for
GIST
Asan Medical Center 48
Testing effectiveness (Phase 2)Looking for participantsNCT06380816
What this trial is testing

A Phase I/II Trial of UCB4594 in Participants With Advanced Cancer

Who this might be right for
Advanced Solid TumoursSquamous Cell Carcinoma of Head and NeckCarcinoma, Non-Small-Cell Lung+8 more
Cancer Research UK 167
Large-scale testing (Phase 3)Active Not RecruitingNCT03673501
What this trial is testing

Ripretinib vs Sunitinib in Advanced GIST Patients After Treatment With Imatinib

Who this might be right for
Gastrointestinal Stromal Tumors
Deciphera Pharmaceuticals, LLC 453
Large-scale testing (Phase 3)Study completedNCT00471328
What this trial is testing

Efficacy and Safety of Nilotinib (AMN107) Compared With Current Treatment Options in Patients With GIST Who Have Failed Both Imatinib and Sunitinib

Who this might be right for
Gastrointestinal Stromal Tumors
Novartis Pharmaceuticals 248
Not applicableStudy completedNCT02489422
What this trial is testing

Programs To Support You During Chemotherapy

Who this might be right for
DepressionFatigueStage IIA Colorectal Cancer+18 more
Wake Forest University Health Sciences 44
Next Page